COBISS Kooperativni online bibliografski sistem in servisi COBISS
Fabrizio Chiodo
Osebna bibliografija za obdobje 2021-2026
2021
1.
BIAGIOTTI, Giacomo, PURIĆ, Edvin, URBANČIČ, Iztok, KRIŠELJ, Ana, WEISS, Matjaž, MRAVLJAK,
Janez, GELLINI, Cristina, LAY, Luigi, CHIODO, Fabrizio, ANDERLUH, Marko, et al. Combining
cross-coupling reaction and Knoevenagel condensation in the synthesis of glyco-BODIPY
probes for DC-SIGN super-resolution bioimaging. Bioorganic chemistry. 2021, vol. 109, str. 1-10, ilustr. ISSN 0045-2068. https://www.sciencedirect.com/science/article/pii/S0045206821001073?casa_token=HzJ-g6Cn8OUAAAAA:eD-hnCXf40Xf_YPGVDoy1051o5Pc2BOdP8Le6m5lXQ5CROwhvZXT0c-UiHe-5Gf7z60lVhJ6cNEa, Repozitorij Univerze v Ljubljani – RUL, DOI: 10.1016/j.bioorg.2021.104730. [COBISS.SI-ID 52587523]
projekt: P1-0208; financer: ARRS
projekt: P1-0060; financer: ARRS
projekt: P1-0208; financer: ARRS
projekt: P1-0060; financer: ARRS
2.
ANDERLUH, Marko, BERTI, Francesco, BZDUCHA-WRÓBEL, Anna, CHIODO, Fabrizio, COLOMBO,
Cinzia, COMPOSTELLA, Federica, DURLIK, Katarzyna, FERHATI, Xhenti, HOLMDAHL, Rikard,
ŠVAJGER, Urban, et al. Emerging glyco-based strategies to steer immune responses.
FEBS journal. [Online ed.]. Aug. 2021, vol. 288, iss. 16, str. 4746-4772, ilustr. ISSN 1742-4658.
https://pubmed.ncbi.nlm.nih.gov/33752265/, DOI: 10.1111/febs.15830. [COBISS.SI-ID 58884867]
2022
3.
ANDERLUH, Marko, BERTI, Francesco, BZDUCHA-WRÓBEL, Anna, CHIODO, Fabrizio, COLOMBO,
Cinzia, COMPOSTELLA, Federica, DURLIK, Katarzyna, FERHATI, Xhenti, HOLMDAHL, Rikard,
ŠVAJGER, Urban, et al. Recent advances on smart glycoconjugate vaccines in infections
and cancer. FEBS journal. [Online ed.]. 2022, vol. 289, iss. 14, str. 4251-4303, ilustr. ISSN 1742-4658. https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.15909, DOI: 10.1111/febs.15909. [COBISS.SI-ID 61513987]
2026
4.
BIAGIOTTI, Giacomo, PURIĆ, Edvin, TRICOMI, Jacopo, MRAVLJAK, Janez, CICCHI, Stefano,
LAURATI, Marco, VAN KOOYK, Yvette van, CHIODO, Fabrizio, URBANČIČ, Iztok, ANDERLUH,
Marko, RICHICHI, Barbara. A nonavalent BODIPY with a multivalent arrangement of α-mannosides
enables lectins recognition in fluorescence-based assays. RSC chemical biology. 2026, vol. , iss. , <v tisku>, ilustr. ISSN 2633-0679. https://pubs.rsc.org/en/content/articlelanding/2026/cb/d5cb00190k, DOI: 10.1039/d5cb00190k. [COBISS.SI-ID 264198147]
projekt: The financial support of this work from the Slovenian Research Agency (Grant P1-0208; P1-0060) is gratefully acknowledged. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS. We also thank Eva Cerkvenik for her assistance in the lab during FCS measurements. GB, JT, SC and BR thank (“Progetto Dipartimenti di Eccellenza 2013–2027”, allocated to the Department of Chemistry “Ugo Schiff”). B. R. thanks L’Amore di Matteo Coveri ONLUS for financial support. S. C. acknowledges the support from the European Union by the Next Generation EU project ECS00000017 ‘Ecosistema dell’Innovazione’ Tuscany Health Ecosystem (THE, PNRR, Spoke 4: Nanotechnologies for diagnosis and therapy). ML acknowledges financial support from the European Union – NextGeneration EU, DM 737/2021, “bando IR@Unifi2023”, Project code HIRES, CUP B55F21007810001, and “Progetto PNRR_CN3_RNA_Spoke_5 – PNRR_CN 3_Centro Nazionale di Ricerca Sviluppo di terapia genica e farmaci con tecnologia a RNA”, CUP B13C220010100012.
projekt: The financial support of this work from the Slovenian Research Agency (Grant P1-0208; P1-0060) is gratefully acknowledged. This research was supported by the Ministry of Education, Science, and Sport (MIZŠ) of the Republic of Slovenia and the European Regional Development Fund OP20.05187 RI-SI-EATRIS. We also thank Eva Cerkvenik for her assistance in the lab during FCS measurements. GB, JT, SC and BR thank (“Progetto Dipartimenti di Eccellenza 2013–2027”, allocated to the Department of Chemistry “Ugo Schiff”). B. R. thanks L’Amore di Matteo Coveri ONLUS for financial support. S. C. acknowledges the support from the European Union by the Next Generation EU project ECS00000017 ‘Ecosistema dell’Innovazione’ Tuscany Health Ecosystem (THE, PNRR, Spoke 4: Nanotechnologies for diagnosis and therapy). ML acknowledges financial support from the European Union – NextGeneration EU, DM 737/2021, “bando IR@Unifi2023”, Project code HIRES, CUP B55F21007810001, and “Progetto PNRR_CN3_RNA_Spoke_5 – PNRR_CN 3_Centro Nazionale di Ricerca Sviluppo di terapia genica e farmaci con tecnologia a RNA”, CUP B13C220010100012.